Beijing Tiantan Biological Products Corporation Limited Class ASSE: 600161

Announcement on Obtaining Notice of Approval for Drug Clinical Trials by Subsidiary

· Issued by Beijing Tiantan Biological Products Corporation Limited Class A via Shanghai Stock Exchange
Announcement on Obtaining Notice of Approval for Drug Clinical Trials by Subsidiary

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment